Compare INBX & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBX | NAMM |
|---|---|---|
| Founded | 2010 | 2024 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.2M | 410.8M |
| IPO Year | 2020 | N/A |
| Metric | INBX | NAMM |
|---|---|---|
| Price | $76.74 | $1.13 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 236.0K | ★ 290.1K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,400,000.00 | ★ $80,348,000.00 |
| Revenue This Year | $563.00 | N/A |
| Revenue Next Year | $230.77 | $109.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.52 |
| 52 Week Low | $10.81 | $1.15 |
| 52 Week High | $94.47 | $55.00 |
| Indicator | INBX | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | N/A |
| Support Level | $79.00 | N/A |
| Resistance Level | $94.47 | N/A |
| Average True Range (ATR) | 5.90 | 0.00 |
| MACD | -2.08 | 0.00 |
| Stochastic Oscillator | 5.29 | 0.00 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.